CHE240517P580000
- 15.00
- 0.000.00%
Chemed Newsroom
Chemed Is Maintained at Outperform by RBC Capital
Chemed Is Maintained at Outperform by RBC Capital
Express News | RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $697
Chemed Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/21/2024 23.98% RBC Capital $712 → $697 Maintains Outperform 03/04/2024 26.65% RBC Capital $604 → $712 M
Analysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)
Express News | Chemed Corp : RBC Cuts Target Price to $697 From $712
Chemed To Go Ex-Dividend On May 30th, 2024 With 0.4 USD Dividend Per Share
May 21st - $Chemed(CHE.US)$ is trading ex-dividend on May 30th, 2024. Shareholders of record on May 30th, 2024 will receive 0.4 USD dividend per share on June 18th, 2024. The ex-dividend date is M
Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable June 18 to Shareholders of Record on May 30
03:52 PM EDT, 05/20/2024 (MT Newswires) -- Chemed Maintains Quarterly Dividend at $0.40 Per Share, Payable June 18 to Shareholders of Record on May 30 Price: 562.72, Change: -2.80, Percent Change: -0.
Press Release: Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend CINCINNATI--(BUSINESS WIRE)--May 20, 2024-- Stockholders of Chemed Corporation (NYSE:CHE) today elected a s
Chemed Corp (CHE) CEO Kevin Mcnamara Sells 4,000 Shares
Chemed(CHE.US) Officer Sells US$2.27 Million in Common Stock
$Chemed(CHE.US)$ Officer MCNAMARA KEVIN J sold 4,000 shares of common stock on May 16, 2024 at an average price of $567.54 for a total value of $2.27 million.Source: Announcement What is statement of
Chemed Insider Sold Shares Worth $2,270,160, According to a Recent SEC Filing
Kevin J McNamara, Director, President and CEO, on May 16, 2024, sold 4,000 shares in Chemed (CHE) for $2,270,160. Following the Form 4 filing with the SEC, McNamara has control over a total of 108,549
Form 144 | Chemed(CHE.US) Officer Proposes to Sell 2.27 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 16, $Chemed(CHE.US)$ Officer MCNAMARA KEVIN J intends to sell 4,000 shares of its common stock on May 16, with a total market value of approximately $2.27 million. Sourc
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
Chemed Corporation's (NYSE:CHE) CEO Compensation Looks Acceptable To Us And Here's Why
Key Insights Chemed will host its Annual General Meeting on 20th of May Total pay for CEO Kevin McNamara includes US$1.60m salary The total compensation is similar to the average for the industry
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las
Peering Into Chemed's Recent Short Interest
Chemed's (NYSE:CHE) short percent of float has fallen 4.97% since its last report. The company recently reported that it has 451 thousand shares sold short, which is 3.44% of all regular shares that a
Chemed Corporation (NYSE:CHE) Q1 2024 Earnings Call Transcript
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Chemed's (CHE) Q1 results were "a rare earnings miss" as its Roto-Rooter unit continued to face pressure in the quarter coupled with ineffective returns on paid advertising, Oppenheimer said in a note
Chemed Corporation Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that Chemed Corporation (NYSE:CHE) released its quarterly result to the market. The early response was not positive, with shares down 4.0% to US$573 in the past week.
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...